Designed to connect business leaders worldwide, Proventa International’s Pharmacovigilance Strategy Meeting does a different approach to bringing organizations the latest regulatory updates and drug safety insights. Unlike other pharmacovigilance conferences, our strategy meeting is exclusive to director-level executives from large and emerging biotech, pharma and IT companies so you can be sure you’re engaging with primary decision makers.
If you’ve been attending drug safety summits or regulatory affairs conferences, you know that the opportunities to raise questions relevant to your business are limited. With the personalized format of our executive roundtable discussions, we assure in-depth discussions of issues that your organization is facing. Delegates with shared key challenges are grouped together to dive deep on pharmacovigilance trends and topics like epidemiology, risk monitoring clinical and patient safety and more. Everyone gets the chance to ask questions or contribute insights to the session.
With the goal to offer more value to our delegates, our pre-arranged one-to-one meetings are another feature you can’t find in pharmacovigilance conferences. Need guidance on medical and regulatory affairs? Contact us and we’ll schedule your one-to-one meeting with an experienced professional from our wide network of pharmacovigilance consultants worldwide.
Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
Clinical & Patient Safety
Medical & Regulatory Affairs
Post Authorisation Safety
For interested delegates and sponsors in Europe, please check out the Clinical Operations Strategy Meeting happening this June 11 in Munich, Germany here.
To see other strategy meetings near you, click here.